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Coupled RNA polymerase II transcription and 39 end
formation with yeast whole-cell extracts
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2Department of Biomolecular Mechanisms, Max Planck Institute for Medical Research, 69120 Heidelberg, Germany
ABSTRACT
RNA polymerase II (RNAP II) transcription and pre-mRNA 39 end formation are linked through physical and functional
interactions. We describe here a highly efficient yeast in vitro system that reproduces both transcription and 39 end formation in
a single reaction. The system is based on simple whole-cell extracts that were supplemented with a hybrid Gal4-VP16
transcriptional activator and supercoiled plasmid DNA templates encoding G-less cassette reporters. We found that the
coupling of transcription and processing in vitro enhanced pre-mRNA 39 end formation and reproduced requirements for
poly(A) signals and polyadenylation factors. Unexpectedly, however, we show that in vitro transcripts lacked m7G-caps.
Reconstitution experiments with CF IA factor assembled entirely from heterologous components suggested that the CTD
interaction domain of the Pcf11 subunit was required for proper RNAP II termination but not 39 end formation. Moreover, we
observed reduced termination activity associated with extracts prepared from cells carrying a mutation in the 59-39 exonuclease
Rat1 or following chemical inhibition of exonuclease activity. Thus, in vitro transcription coupled to pre-mRNA processing
recapitulates hallmarks of poly(A)-dependent RNAP II termination. The in vitro transcription/processing system presented here
should provide a useful tool to further define the role of factors involved in coupling.
Keywords: transcription; 39 end formation; termination; yeast, extracts; G-less cassette
INTRODUCTION
In order to function as templates for protein synthesis, the
primary RNAP II transcripts must experience the addition
of a 7-methyl-guanosine (m7G) cap to the 59 end and receive
a poly(A) tail at the 39 end. Interestingly, these pre-mRNA
processing reactions are physically and functionally linked to
transcription via the carboxyl-terminal domain (CTD) of the
largest subunit of RNAP II (McCracken et al. 1997). During
the transcription cycle, the association of capping and 39 end
formation factors, respectively, is controlled in a dynamic
fashion through differential phosphorylation of the CTD
(Buratowski 2009). Phosphorylation on serine-5 following
the transcription initiation promotes the association of cap-
ping factors (Komarnitsky et al. 2000; Schroeder et al. 2000),
whereas phosphorylation of serine-2 at 39 ends of genes
coincides with the association of the 39 end formation
machinery (Ahn et al. 2004).
RNA synthesis by RNAP II is a highly processive reaction,
and its termination is intimately linked to 39 end formation
(Proudfoot 2004; Richard and Manley 2009). RNA signals on
the emerging nascent transcript determine the site of poly(A)
addition and trigger the subsequent termination of RNAP
II transcription (Logan et al. 1987). Two major models have
been proposed that outline the mechanistic details of the
molecular events that are thought to occur during termina-
tion. On the one hand, the ‘‘allosteric’’ model predicted that
following the transcription of a poly(A) signal the proper-
ties of RNAP II change, possibly due to the dissociation
of processivity factors or the association of termination
factors (Logan et al. 1987). The ‘‘torpedo’’ model, on the
other hand, relies on the endonucleolytic cleavage associated
with the 39 end formation reaction (Connelly and Manley
1988). Cleavage provides an entry site for 59-39 exonucleases
to degrade the downstream cleavage product and to
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transduce to RNAP II that a poly(A) signal has been
recognized. Work from many different laboratories provided
evidence supporting both models (Richard and Manley 2009).
Thus, it seems likely that a combination of allosteric and
torpedo models and variations thereof ensure the efficient
termination of RNAP II at different genes (Luo et al. 2006;
Gilmour and Fan 2008).
The factors involved in pre-mRNA 39 end formation
display a remarkable complexity, and many open questions
remain concerning the function of the individual subunits
(Zhao et al. 1999; Mandel et al. 2008). In Saccharomyces
cerevisiae, the major activities required to reconstitute 39 end
formation in vitro are contained within the cleavage factors
IA and IB (CF IA and CF IB) (Kessler et al. 1996) and the
cleavage and polyadenylation factor (CPF) (Dichtl et al.
2002). CF IB contains a single polypeptide, Nab4/Hrp1
(Kessler et al. 1997; Minvielle-Sebastia et al. 1998), and
CPF consists of some 15 different subunits (Dichtl et al.
2002; Nedea et al. 2003). The four proteins Rna14, Rna15,
Clp1, and Pcf11 constitute CF IA (Minvielle-Sebastia et al.
1997). Rna14 and Rna15 form a tight heterodimer and are
involved in poly(A) site recognition in part via the RRM
RNA binding domains of the Rna15 protein (Minvielle-
Sebastia et al. 1994). Clp1 is a ATP binding protein that was
found to carry 59 RNA kinase activity in humans and archaea
(Weitzer and Martinez 2007; Jain and Shuman 2009); however,
no such activity was found associated with the yeast protein
(Noble et al. 2007; Ramirez et al. 2008). The Pcf11 protein
directly tethers CF IA to the RNAP II CTD via an N-terminal
CTD interaction domain (CID) (Amrani et al. 1997; Sadowski
et al. 2003; Meinhart and Cramer 2004; Zhang et al. 2005).
In vitro systems were instrumental to dissect the machin-
eries and mechanisms involved in transcription and pre-
mRNA 39 end formation. Yeast transcription was studied in
vitro with extracts and G-less reporter constructs to analyze
the mechanisms of initiation (Lue et al. 1989; Woontner and
Jaehning 1990; Woontner et al. 1991) and elongation
(Rondon et al. 2003, 2004). In contrast, 39 end formation
reactions with mammalian nuclear extracts or yeast extracts
are usually supplemented with synthetic, radioactively la-
beled precursor molecules (Moore and Sharp 1985; Butler
and Platt 1988). Since optimal biochemical conditions for
transcription and processing reactions in vitro can vary sub-
stantially, the establishment of coupled systems was achieved
so far only with labor intensive nuclear extracts obtained
from mammalian sources (Tran et al. 2001; Adamson et al.
2005; Kazerouninia et al. 2010) and yeast (Hyman and
Moore 1993). A coupled system on the basis of whole-cell
yeast extracts was previously introduced but remained
largely uncharacterized (Bucheli and Buratowski 2005).
Here, we describe a highly efficient yeast transcription
system that supports pre-mRNA 39 end formation. The re-
actions are based on whole-cell extracts (WCEs) and G-less
reporter constructs that are driven by a Gal4-VP16 tran-
scriptional activator. With CF IA depletion and reconstitu-
tion experiments, we find that the CID of Pcf11 is required
for in vitro termination efficiency but not 39 end formation.
Analysis of mutant extracts and chemical inhibition of 59-39
exonuclease activity supports a role for the Rat1 exonuclease
in in vitro termination. Thus, this coupled in vitro tran-
scription/processing system recapitulates hallmarks of RNA
synthesis in vivo. We expect this approach to be useful for
the further dissection of protein factors mediating the func-
tional coupling of transcription and pre-mRNA processing.
RESULTS AND DISCUSSION
An improved G-less cassette transcription system
Yeast WCEs were previously used to study transcription
initiation (Lue et al. 1989; Woontner et al. 1991) and
elongation (Rondon et al. 2004). We adapted and modified
these approaches in order to establish a coupled system that
reproduced an entire transcription cycle and associated
39 end formation reactions with WCEs that were supple-
mented with supercoiled plasmid templates and the Gal4-
VP16 transcriptional activator. Transcription reactions with
yeast extracts are frequently accompanied by the accumu-
lation of unspecific reaction products (Lue et al. 1989;
Woontner and Jaehning 1990). To allow the direct analysis
of radioactive transcription products on gels, we chose
therefore to analyze templates containing stretches devoid
of G residues (G-less cassettes) (Lue et al. 1989). In vitro
transcription products are treated with RNase T1 that cleaves
39 of guanosines, leaving only RNase T1-resistant G-less
RNAs intact, which can then be resolved on a denaturing gel.
Figure 1A depicts the features of the analyzed template on
which transcription was driven by a GAL4-CYC1 hybrid pro-
moter. The encoded transcript carries five G-less stretches
with variable length (84, 100, 120, 131, and 145 bp). The 84
cassette is placed right at the transcription start, and its
relative abundance compared with the 100 cassette gives
a measure for the efficiency of transcription elongation
(Rondon et al. 2003). The relative abundance of downstream
cassettes (120, 131, and 145) compared with the transcrip-
tion of the 100 and 84 cassettes, respectively, is influenced by
termination of RNAP II transcription. Furthermore, degra-
dation of the downstream products arising from 39 end
cleavage of pre-mRNA transcripts may be promoted through
interaction of the 59-39 exonuclease Rat1 with the 39 end
formation machinery (Luo et al. 2006).
Initially, we optimized reaction conditions in order to
support both transcription and processing activities asso-
ciated with our extracts. Since 2% (w/v) polyethylene glycol
8000 (PEG 8000) is important for efficient in vitro 39 end
processing (Butler and Platt 1988; Minvielle-Sebastia et al.
1994), we included this reagent in the reactions. Further-
more, we found that substitution of KCl (80–120 mM, as
was used by Rondon et al. 2003) by 125 mM K-glutamate/
5 mM KAc enhanced in vitro transcription. The combined
Mariconti et al.
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adjustments of reaction conditions increased transcrip-
tional activity of the extracts more than threefold compared
with the initially tested conditions (data not shown). Figure
1B shows products of a typical transcription reaction before
RNase T1 digestion. The template carrying the CYC1 ter-
minator sequence (Fig. 1B, lane 2) gave rise to the expected
0.5-kb transcript and an additional
1.3-kb RNA that most likely resulted
from transcriptional read-through at
the CYC1 terminator because it was also
observed with a construct lacking ter-
minator sequences (Dterm; lane 3). Ad-
ditional unspecific and mostly high-
molecular-weight RNAs can be observed
in the absence of an added template
(lane 1) or with a construct lacking pro-
moter sequences (lane 4). This demon-
strated the necessity for RNase T1 di-
gestion to allow the specific analysis of
G-less RNAs. Figure 1C shows the RNase
T1–resistant products obtained with the
construct lacking terminator sequences.
We observed the accumulation of six
RNAs that were derived from the five
G-less cassettes (lane 1). The 84 cassette
gave rise to two signals (84a and 84b),
whereby the shorter RNA resulted from
alternative initiation of RNAP II within
the cassette (Hahn et al. 1985; Lue et al.
1989). Efficient transcription required
the presence of the Gal4-VP16 transcrip-
tional activator (lane 2), and the reac-
tions were sensitive to the RNAP II in-
hibitor a-amanitin (lanes 3, 4). Thus,
transcription of all cassettes resulted
from RNAP II initiation at the GAL4-
CYC1 hybrid promoter. In this work, we
have not determined the number of tran-
scripts that was obtained from each tem-
plate, but the Jaehning laboratory pre-
viously reported the synthesis of 0.018
transcripts per template within 30 min
under comparable conditions (Woontner
et al. 1991). However, the contribution
of RNA degradation was not analyzed in
these studies, and we showed that RNA
stability significantly affected the accu-
mulation of products (see Fig. 5 below).
Thus, steady-state in vitro analyses may
have underestimated the number of
initiation events per template, and it
remains a possibility that in vitro tran-
scription may support multiple rounds
of initiation from the same template.
In vitro transcription coupled to 39 end formation
Next, we analyzed kinetics of G-less transcription of the
Dterm construct with wild-type WCE (Figure 2A, lanes
17–24). Interestingly, we observed that the ratio of 100/84
cassettes increased from 40% to 100% during the first
FIGURE 1. In vitro transcription/processing with yeast whole-cell extracts. (A) Schematic
presentation of transcription templates used to study the transcription/processing in vitro. The
main features of the construct include Gal4 binding sites, a CYC1 promoter, and five G-less
cassettes. Numbers indicate the length of the cassettes and distances separating those,
respectively. CYC1 terminator sequences were inserted between the 100 and 120 cassettes; also
indicated are specific sequence elements (EE, the efficiency element; PE, positioning element;
UUE, upstream U-rich element; DUE, downstream U-rich element; and the poly(A) site). The
cyc1-512 mutation encompasses a 38-bp deletion of sequence elements as indicated. The
products of in vitro transcription are z0.5 kb in length in case of polyadenylated RNA and
>1.3 kb in case of read-through transcripts. Between 84 and 100 G-less cassettes, the site
of complementarity for oligo UP (arrow tail) is indicated that was used for linker-mediated
39 end analysis (see Fig. 3D). (B) RNAs obtained from in vitro transcription reactions with
wild-type extract and Gal4-VP16 activator were separated on 1.2% denaturing formaldehyde
agarose gel, transferred to Hybond N+ membrane, and exposed to a Fujifilm imaging plate.
Supercoiled plasmid template carrying reporter construct with the CYC1 terminator (lane 2),
no terminator (lane 3), or no GAL4-CYC1 promoter (lane 4) was analyzed; template was
omitted in lane 1. (C) In vitro transcription reaction with wild-type extract, Gal4-VP16
activator, and a supercoiled plasmid template carrying the reporter construct without
terminator (lane 1). RNase T1 digestion of transcription products released G-less RNAs,
which were analyzed by denaturing gel-electrophoresis. The length of the RNAs is indicated
on the left. The Gal4-VP16 transcriptional activator was omitted in the reaction shown in lane
2. Reactions analyzed in lanes 3,4 contained 10 and 20 ng/mL a-amanitin, respectively.
mRNA synthesis with yeast whole-cell extracts
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60 min of the time-course (Figure 2B, right-hand bars).
Assuming an elongation rate of 1–2 kb/min that is typically
measured for RNAP II in vivo (Mason and Struhl 2005;
Boireau et al. 2007), we would have expected that RNAP
II completed the transcription of both cassettes (311 nt
distance) within the first 5 min of the reaction. The
synthesis of the first 311 nt of the transcript may therefore
occur with a reduced efficiency, and we speculate that this
may be due, for example, to RNAP
II pausing. Our finding that G-less RNAs
do not carry a m7G-cap (see Fig. 5,
below) may affect early elongation and
thus may be related to this observation. In
contrast, the 120/100 and 131/100 ra-
tios, and to a lesser extent the 145/100
ratio, remained constant during the time-
course. Thus, early elongation may have
a limited transcription efficiency, and the
rate of transcription may vary consider-
ably along the template. In an alternative
scenario, RNA degradation may restrict
the accumulation of G-less cassettes and,
in combination with increasing proces-
sivity of RNAP II during the time-course
(i.e., the increased ability of the enzyme to
remain associated with the template),
could also positively affect the ratio of
the 100/84 cassettes. Thus, the possibility
remains that early transcribed RNAs (that
were synthesized at lower processivity)
are already largely degraded when RNA
synthesis takes place with higher proces-
sivity at the later time points. We do not
favor this explanation for two reasons: (1)
low processivity of RNAP II transcrip-
tion would be expected to result in dis-
sociation of the enzyme also within
G-less cassettes and should therefore
produce a smear of G-less signals that is
clearly not observed in our experiments,
and (2) it is unclear why the properties
of RNAP II (i.e., its processivity) would
change during the time-course.
We also observed an overall reduc-
tion of G-less transcription with the
increasing length of the RNA. About
80% of polymerases that reached the
100 cassette continued synthesis of the
120 and 131 cassettes, while only 60% of
those polymerase molecules made it
past the 145 cassette. This apparent
tendency of RNAP II to dissociate from
the template may reflect in vitro tran-
scription conditions and contrasts the
high processivity observed with RNAP
II in vivo (Mason and Struhl 2005).
Introduction of terminator sequences from the well-
studied iso-1-cytochrome c (CYC1) gene between the 100
and 120 cassettes (Fig. 1A) resulted in the reduced ac-
cumulation of G-less cassettes originating from sequences
downstream from the terminator (Fig. 2A, lanes 1–8),
suggesting that 39 end formation and termination occurred
in vitro. Typically, the amount of downstream 120, 131,
FIGURE 2. In vitro termination is dependent on functional poly(A) signals. (A) Time-course
of in vitro transcription reactions with wild-type extracts and templates carrying wild-type
CYC1, mutant cyc1-512, or no terminator sequences (Dterm) as indicated. (B) Quantification
of the gels shown in A. The obtained signals were normalized to uridine content of the cassettes
and presented as a percentage of G-less transcription. Transcriptional elongation efficiency is
indicated by the 100/84 ratio. Termination and 39 end formation is reflected by the 120/100,
131/100, and 145/100 signals. (C) Presentation of the 40-min time point of the time-course
experiments shown in A as a function of the distance of G-less transcription relative to the site
of poly(A) addition, which has been fixed at ‘‘0’’ bp. The signal obtained with the 100-bp
cassette was fixed at 100%; the 120/100, 131/100, and 145/100 ratios provide the other data
points.
Mariconti et al.
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and 145 cassettes observed was z25%–40% relative to the
100 cassette (Fig. 2B, left-hand bars; C). The cyc1-512
mutation carries a 38-bp deletion, including efficiency and
positioning elements involved in 39 end formation (Fig.
1A); this mutation is known to confer both defective 39 end
formation in vitro (Butler and Platt 1988) and transcrip-
tional read-through in vivo (Zaret and Sherman 1982). To
test whether the reduction of G-less transcripts downstream
from the CYC1 terminator was due to 39 end formation
and/or poly(A) driven termination, we analyzed constructs
that carried a mutant cyc1-512 terminator. As shown in
Figure 2A, this construct behaved similar to the Dterm
construct, indicating that the 39 end formation/termination
was indeed defective (lanes 9–16). However, downstream
cassettes’ levels were somewhat reduced compared with the
Dterm construct (Fig. 2C), a finding that is consistent with
the previous observation that some residual termination
activity remains associated with the cyc1-512 allele (Zaret
and Sherman 1982).
In vitro 39 end formation/termination depends
on poly(A) factors
Next, we wanted to demonstrate the requirement of poly(A)
factors for in vitro 39 end formation/termination. For this
purpose, we produced extracts from strains expressing
Rna15 and Pfs2 that are fused at the amino terminus to
a ProtA-tag and that stably associate with CF IA and CPF,
respectively. The ProtA-fusion proteins were depleted from
the extracts by two consecutive rounds of adsorption to IgG-
Sepharose; the bound factors were retrieved by tobacco etch
spot virus (TEV) protease cleavage and used for comple-
mentation analyses (Fig. 3A). Western blot analysis of ex-
tracts before and after depletion revealed a substantial re-
moval of the ProtA-fusion proteins (estimated >90%) (Fig.
3A). In vitro transcription reactions with nondepleted
extracts had low levels of downstream cassettes with the
wild-type CYC1 terminator (Fig. 3B, lanes 1, 7) but not with
the cyc1-512 mutant (lanes 2, 8), as expected. In contrast,
both extracts depleted for the ProtA-tagged proteins dis-
played the prevailing signal strength associated with down-
stream 120, 131, and 145 cassettes (lanes 3, 9). This effect
was a direct consequence of the removal of the 39 end for-
mation factors since add-back of partially purified CF IA
and CPF, respectively, to the depleted extracts restored the
activity (Fig. 3B, lanes 4–6, 10–12).
To correlate the defects observed in the absence of 39 end
formation factors with 39 end cleavage and polyadenyla-
tion, we analyzed RNA obtained from nonradioactive in
vitro transcription reactions, using a ligation-based RT-
PCR technique as outlined in Figure 3D; this procedure will
be described in detail elsewhere (RA Alexander, M Kos, MC
Robert, B Dichtl, JD Barrass, T Obtulowicz, M Koper, I
Karkusiewicz, L Mariconti, D Tollervey, et al., in prep.).
The protocol starts with the attachment of a 59 phosphor-
ylated DNA oligonucleotide linker to the available 39 OH
groups by T4 RNA ligase. The resulting ligation products
are then reverse transcribed using a primer that anneals
to the linker oligonucleotide, and amplified by PCR with
primers that anneal upstream of the terminator (oligo UP)
(Fig. 1A) or to the linker sequence. With this approach, the
efficiency and the site of 39 end cleavage as well as the
length of the added poly(A) tail can be determined. RT-
PCR products obtained from in vitro transcription of the
construct carrying the CYC1 terminator gave the expected
DNA fragment of z500 bp length (Fig. 3D, lane 1). DNA
sequencing of 12 independent 39 ends revealed that 39 end
cleavage in vitro occurred in 11 cases between the CYA at
position 504 relative to the CYC1 translational start codon
and thus at the same position as in cells (Guo et al. 1995).
All 39 ends also carried poly(A) stretches that varied in
length between 16 and 68 adenosine residues, showing that
polyadenylation and poly(A) length control occurred effi-
ciently in our in vitro system (see also Fig. 6B, below). The
cyc1-512 construct gave only very small amounts of am-
plified product with slightly reduced length due to the
38-bp deletion within the poly(A) signal sequences (Fig. 3D,
lane 2). This indicated that some residual cleavage occurred
at the mutant terminator in vitro. Extracts depleted for
ProtA-tagged Pfs2 and ProtA-tagged Rna15 gave reduced
amounts of PCR product (Fig. 3D, cf. lanes 3, 5, as well as
lanes 8, 10), reflecting loss of the 39 end cleavage activity.
Likewise, the add-back of CPF and CF IA factors reestab-
lished the accumulation of PCR product (lanes 6, 7 and 11,
12, respectively).
rat1-1 extracts are deficient for termination
but proficient for 39 end cleavage
According to the torpedo model of termination, 39 end
cleavage produces an entry site for a 59/39 exonuclease to
promote efficient release of RNAP II from the transcription
template. It has been shown that the 59/39 exonuclease
Rat1 plays a role for termination in vivo (West et al. 2004;
Kim et al. 2004; Luo et al. 2006; Kaneko et al. 2007), but
Rat1 and its interaction partners Rai1 and Rtt103 were not
sufficient to terminate immobilized RNAP II in a highly
defined in vitro situation (Dengl and Cramer 2009). We
initially produced extracts from rat1-1 mutant strains and
performed in vitro transcription reactions. Figure 4A shows
a typical time-course experiment with the CYC1 and cyc1-
512 constructs. Quantification revealed an apparent in-
crease of transcriptional read-through with rat1-1 extracts
since the levels of downstream 120, 131, and 145 cassettes
remained at 60% with the wild-type terminator (Fig. 4B);
notably, these values were z30% with wild-type extracts
(Fig. 2C). Furthermore, the 120 and 131 cassette transcrip-
tion remained close to 100% with the mutant terminator,
suggesting that the termination defect of the cyc1-512 allele
was exacerbated with the mutant extract.
mRNA synthesis with yeast whole-cell extracts
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RT-PCR analysis of 39ends revealed
that 39 end cleavage occurred efficiently
with the rat1-1 extracts and the wild-type
CYC1 terminator (Fig. 4C, lanes 1–5),
consistent with previous results (Kim
et al, 2004). In contrast, cleavage was
strongly reduced with the mutant ter-
minator, as expected (lanes 6–9). Taken
together, our analyses support the idea
that Rat1 contributed to termination in
the coupled transcription/processing as-
say and that increased transcriptional
read-through occurred independently
of defects in 39 end cleavage.
pAp-mediated inhibition of 59-39
exonuclease activity increases
transcriptional read-through
We previously showed that the metabo-
lite adenosine 39,59 bisphosphate (pAp),
a side-product of sulfate assimilation,
efficiently inhibits 59/39 exonuclease
activity in yeast cells (Dichtl et al. 1997).
In vitro analysis showed, furthermore,
that the presence of 0.4–1 mM pAp
resulted in inhibition of up to 80% of
Rat1 activity (Dichtl et al. 1997). There-
fore, we evaluated the role of exonucle-
ase activity in termination using this
potent inhibitor in our in vitro tran-
scription system. Figure 5A shows that
the presence of up to 4 mM pAp did not
interfere with the efficiency of in vitro
transcription. Furthermore, the signals
of downstream 120, 131, and 145 cas-
settes were clearly enhanced in the pres-
ence of increasing concentrations of the
metabolite. Quantification of the bands
confirmed that the levels of downstream
cassettes were increased from z30% in
the absence of pAp to z60% in the
presence of 2 and 4 mM pAp, respec-
tively (Fig. 5B). Since these values com-
pare well with the levels of downstream
cassettes in the rat1-1mutant, it appears
that exonuclease activity of Rat1 con-
tributed to the apparent termination in
our assay. To exclude that this effect
was due to reduced 39 end cleavage, we
analyzed 39 ends of RNA synthesized in
the presence of pAp. We found that
39 end cleavage was comparable in the
absence and presence of the metabolite
(Fig. 5C).
FIGURE 3. Requirement for 39 end formation factors for coupled in vitro transcription and
processing. (A) Scheme of whole-cell extract (WCE) preparation and factor depletion
employed in this work for CF IA–associated ProtA-tagged Rna15 and CPF-associated
ProtA-tagged Pfs2, respectively. Also shown is a Western blot of ProtA-tagged Rna15 and
ProtA-tagged Pfs2 proteins to control the efficiency of factor depletion. (B) In vitro
transcription/processing reactions with constructs carrying the wild-type CYC1 terminator
and with extracts before (lanes 1,7) and after (lanes 3–6,9–12) depletion of the indicated
ProtA-tagged proteins as described in A. One, two, and four microliters of CF IA and CPF
factor, respectively, was added back to depleted extracts (lanes 4–6,10–12). For control,
reactions were also done with nondepleted extracts on templates carrying the mutant cyc1-512
terminator (lanes 2,8). (C) Quantification of results obtained in B. (D) Schematic represen-
tation of the procedure to analyze 39 end formation. Nonradioactive in vitro transcription
reactions were performed, and the obtained RNAs were used to add a 59 phosphorylated DNA
oligonucleotide linker with T4 RNA ligase. The ligation products were reverse transcribed and
amplified by PCR. The employed PCR primers were oligo UP (complementary to region
between the 84 and 100 cassette; see Fig. 1A) and oligo B, which is complementary to the DNA
linker. The amount of PCR product obtained with this method reflects the efficiency of pre-
mRNA 39 end cleavage. Analyzed were a wild-type extract on the CYC1 terminator (lane 1) and
cyc1-512 mutant (lane 2) templates. ProtA-tagged Pfs2 and ProtA-tagged Rna15 extracts were
analyzed before (lanes 3,4,8,9) and after (lanes 5–7,10–12) factor depletion. Two and four
microliters of CPF and CF IA factor, respectively, was added back to depleted extracts (lanes
6,7,11,12). To ensure that signals were derived from RNA, reverse transcriptase enzyme was
omitted from reactions analyzed in lanes 4,9.
Mariconti et al.
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Interestingly, the presence of pAp also resulted in an
apparent increase of 84a, 84b, and 100 cassettes (Fig. 5A),
indicating that the in vitro transcripts were also attacked by
59-39 exonucleases from the very 59 end. This observation
was surprising since these transcripts were expected to be
protected by the m7G-cap structure. We used monoclonal
H 20 antibodies that bind the m7G-cap with high affinity
(Bochnig et al. 1987) in immunoprecipitation experiments
to test for the presence of a m7G-cap on our in vitro tran-
scripts. Figure 5D shows that G-less transcripts made by
RNAP II were not precipitated by the H 20 antibody, just
like G-less transcripts that were produced in the extracts by
supplemented T3 RNA polymerase (T3 RNAP) (see Fig. 6)
and that were not expected to carry a cap. In contrast,
a capped luciferase transcript that was obtained by in vitro
transcription with the T7 Ribomax kit from Promega was
bound efficiently. We conclude that G-less transcripts made
by RNAP II in our in vitro system were largely if not com-
pletely devoid of a m7G-cap structure. G-less mRNAs were
therefore susceptible to 59-39 degradation, similar to the re-
cently reported Rat1-dependent degradation of uncapped
mRNAs in vivo (Jimeno-Gonzalez et al. 2010). It remains to
be determined in future experiments whether the in vitro
transcription system did not support capping or whether
capped transcripts were rapidly decapped in the WCEs.
We wanted to further characterize the influence of RNA
degradation on the steady-state accumulation of G-less cas-
settes. For this purpose, we performed in vitro transcription
and analyzed the decay of accumulated
RNAs following a-amanitin inhibition
of RNAP II in the WCEs (Fig. 5E, lanes
1–6). Interestingly, we found that G-less
RNAs located upstream of (100 cassette)
and downstream from (130 cassette) the
poly(A) site showed a very similar decay
profile (Fig. 5F). This is consistent with
the observation that G-less RNAs con-
taining upstream cassettes did not carry
a m7G-cap that would have increased
their stability. The contribution of 59-39
exonucleases to degradation was evalu-
ated by addition of 4 mM pAp at the
time of RNAP II inhibition (Fig. 5E).
This resulted in strong stabilization of
the RNAs, suggesting that 59-39 exonu-
cleases were responsible for most of the
observed degradation activity. Impor-
tantly, these experiments did not reveal
a possible preferential degradation of
transcription products in this in vitro
system. Thus, the apparent accumulation
of G-less cassettes that we measure at
steady-state may produce a faithful pic-
ture of transcription elongation (Fig. 2B)
and termination (Figs. 3C, 4B, 5B).
T3 RNAP does not terminate transcription
at the CYC1 terminator
We show that both pre-mRNA 39 end formation and tran-
scription termination can be reproduced in a coupled
transcription/processing assay in vitro. A heterologous
RNA polymerase lacking the CTD is, however, not expected
to support such coupling and should reveal the extent of
post-transcriptional RNA processing that is associated with
our assays. To test this, we placed our G-less reporter con-
structs under control of the promoter specific for the phage
T3 RNAP and complemented the extracts with commer-
cially available T3 RNAP enzyme. To avoid saturation of
the processing capacities associated with the extracts, we
adjusted the transcriptional output by T3 RNAP to signals
obtained with extracts containing RNAP II (Fig. 6A, lanes
1–7). 39 end analysis of the time-course experiments re-
vealed that 39 end formation occurred with the transcripts
made by both RNAP II and T3 RNAP (Fig. 6B). We used
sequencing to determine the site of poly(A) addition on 12
independent T3 transcripts and found that poly(A) addi-
tion occurred faithfully at the CYA position 504 relative to
the CYC1 translational start codon and included 36–66
adenosine residues. A time-course experiment revealed that
39 end formation coupled to RNAP II occurred with higher
efficiency compared with the T3 RNAP reaction (Fig. 6B,
upper panel). Since neither RNAP II nor T3 RNAP
transcripts carry m7G-cap, this difference is unlikely to
FIGURE 4. Analysis of rat1-1 extracts in coupled in vitro transcription/processing. (A) Time-
course of in vitro transcription/processing with rat1-1 mutant extracts with templates carrying
wild-type CYC1 (lanes 1–5) and mutant cyc1-512 (lanes 6–10) terminators, as indicated. (B)
Quantification of results obtained in A. (C) 39 end analysis as outlined in Figure 3D, of time-
course obtained with rat1-1 in vitro transcription/processing reactions. Minus reverse
transcriptase (RT) controls were included for 40 min time points (lanes 5,10).
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result from differential stability. High-resolution analysis of
radioactively marked PCR products on acrylamide gels
suggested, however, that the distribution of poly(A) was
comparable in both cases, consistent
with our sequencing results (Fig. 6B,
lower panel). The appearance of shorter
poly(A) species with increasing time
likely results from deadenylation activ-
ities in the extracts.
Next, we compared in vitro tran-
scription with T3 RNAP on constructs
differing in terminator sequences (Fig.
6A, lanes 8–10). G-less transcripts ob-
tained with the Dterm construct indi-
cated some gradual loss of polymerase
activity along the template (z80% sig-
nal at the 120 and 131 cassettes and
z60% signal at the 145 cassette) similar
to what we observed with endogenous
RNAP II (Fig. 2C). Transcription of
cyc1-512 gave virtually identical results.
The wild-type CYC1 terminator reduced
downstream cassette signals to z60%
relative to the 100 cassette. Taken to-
gether, we conclude that transcription
with T3 RNAP cannot support efficient
39 end formation and termination as
observed with RNAP II.
Efficient termination requires
the CID of Pcf11
Next, we tested the role of the Pcf11
CID in pre-mRNA 39 end formation
and termination. Recombinant CF IA
factor (recCF IA) was assembled en-
tirely from Pcf11DN288 (lacking the
CID), Clp1, Rna14, and Rna15 proteins
that were expressed in Escherichia coli
(see Materials and Methods; Fig. 7A).
Attempts to produce recCF IA factor
that included full-length Pcf11 were not
successful due to the limited solubility
of this protein. To circumvent this
problem, we isolated CF IA from yeast
via ProtA-tagged Rna15 (scCF IA). Ini-
tially, we tested 39 end cleavage activity
of recCF IA and found that the factor
complemented the ProtA-tagged Rna15-
depleted extract with an efficiency com-
parable to scCF IA (Fig. 7B). Next, we
used the same ProtA-tagged Rna15-
depleted extracts and CF IA factors
and analyzed transcription of our G-less
reporter constructs (Fig. 7C). Quantifi-
cation revealed that the 120/100 and 131/100 cassette ratios
were elevated from z40% to 80% following depletion of
ProtA-tagged Rna15 (Fig. 7D, cf. lanes 1 and 3), as was
FIGURE 5. Effects of 39,59 adenosine bisphosphate (pAp) on in vitro transcription/processing
with wild-type extracts. (A) In vitro transcription/processing with wild-type extracts with
template carrying wild-type CYC1 terminator in the presence of increasing amounts of pAp, as
indicated. (B) Quantification of results obtained in A. (C) 39 end analysis as outlined in Figure
3D, of time-course of in vitro transcription/processing reactions in the absence and presence of
4 mM pAp. For control, a reaction lacking reverse transcriptase (RT) was included for the
40-min time point, and the mutant cyc1-512 terminator was analyzed in the absence of pAp.
(D) Immunoprecipitation of RNAs obtained from RNAP II and T3 RNAP-dependent
transcription reactions, respectively. Luciferase mRNA served as positive control and was
capped using the T7 Ribomax kit from Promega. Note that in vitro capping of the later RNA is
not complete, accounting for the nonbound luciferase mRNA that is found in the supernatant
(lane 3). RNAs bound to protein A–Sepharose in the presence and absence of anti-m7G
antibody H 20 were separated into unbound (S) and bound fractions (P) and analyzed as
described in the legend of Figure 1B. (E) Decay of G-less RNAs was analyzed following the in
vitro transcription of the CYC1 terminator template with wild-type extracts. After 30 min of
reaction time, RNAP II was inhibited by adding 20 ng/mL a-amanitin together with H2O
(lanes 1–6) or 4 mM pAp (lanes 7–12). Aliquots were removed from the reaction at the
indicated times and analyzed as shown in Figure 1C. (F) Quantification of 100 and 130 G-less
cassettes from E.
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shown above (Fig. 3C). Addition of scCF IA resulted in full
complementation of this defect (Fig. 7D, lanes 5, 6), while
recCF IA carrying the mutant Pcf11 protein was only
partially active to reduce the 120/100 and 131/100 ratios
to z60% (Fig. 7D, lanes 8, 9). We included 4 mM pAp in
some of those reactions to control for the contribution of
exonuclease-mediated degradation of G-less cassettes to the
apparent phenotype. We observed for both the scCF IA and
the recCF IA complemented reactions that pAp enhanced
the levels of downstream cassettes (Fig. 7D, cf. lanes 6, 7 and
9, 10). Thus, the elevated levels of downstream cassettes
observed with recCF IA are likely to result from defective
termination and not because of increased G-less cassette
stability. We conclude that deletion of the Pcf11 CID did
not interfere with the 39 end cleavage but resulted in en-
hanced transcriptional read-through. It remains possible,
however, that differences between recCF IA and scCF IA
may also arise due to potential post-translational modifi-
cations that would be absent on the recombinant factor.
Taken together, these observations are consistent with a role
for Pcf11 in RNAP II termination independent of its role
in pre-mRNA 39 end cleavage (Zhang et al. 2005; Sadowski
et al. 2003).
In summary, we present an extract-based coupled tran-
scription/processing system that reproduces hallmarks of
RNAP II transcription and of pre-
mRNA 39 end formation. The possibil-
ity to analyze extracts prepared from
widely available mutant yeast strains
and to biochemically manipulate ex-
tracts by protein depletion and recon-
stitution of activities invite future in
vitro analyses of factors that have pre-
viously been implicated in these pro-
cesses based on genetic or other in vivo
data. We believe that the assay system
presented here will be a valuable meth-
odological alternative to foster the anal-
ysis of transcription and associated pro-
cesses.
MATERIALS AND METHODS
Yeast strains and plasmid constructs
Strains analyzed in this work were as follows:
‘‘Wild-type’’ W303 (MAT a ade2 leu2 ura3
trp1-1 his3), ProtA-RNA15 (Mata ura3-1 trp1-1
ade2-1 leu2-3,112 his3-11,15 rna15::TRP1
[ProtA-RNA15-LEU2-CEN]; Dichtl et al.
2002), ProtA-PFS2 (Mata ura3 ade2-1 leu2,3-
112 his3-11,15 trp1 pfs2::TRP1 [ProtA-PFS2-
LEU2-CEN]; Ohnacker et al. 2000), and rat1-1
(Mat alpha ura3-52 leu2D1 his3D200 rat1-1;
Amberg et al. 1992).
Plasmids carrying G-less reporters that
were constructed in this study are shown in Table 1. The CLP1
open reading frame was fused to an N-terminal hexahistidine tag
in vector pGM10, resulting in pBD137. For a bicistronic expres-
sion construct encoding Rna14 and Rna15 proteins, the gene of
RNA14 was cloned into pET28b (GE Healthcare) using oligos
Rna14_for 59-GCATGCCATGGCGATGTCCAGCTCTACGACTC-39
and Rna14_rev 59-CTCCCAAGCTTTTAACCTGACTTGGTG
CTC-39. RNA15 was amplified with a 59 primer introducing a
HindIII site, a ribosome binding site, and a start codon (59-CCCA
AGCTTAATAATTTTGTTTAACTTTAAGAAGGAGATATACAT
ATGAATAGGCAGAGCGGTG-39) and a 39 primer (59-AAGTTT
AGCGGCCGCAAATGCACCAAATTCTCCC-39) and ligated into
the HindIII/NotI sites of the pET28a-RNA14 expression construct
in frame with a C-terminal hexahistidine tag. A PCF11 fragment
(PCF11DN288) lacking the CID-interacting domain and the Q-rich
linker was amplified with the primers Pcf11_for 59-CGAGGATCC
TCCTCTCTTTTTGGTAATATTTCTG-39 and Pcf11_rev (59-CAT
AGTTAGCGGCCGCTTATTTTGTGACCAATTTCTTTAAGTCA
TCC-39) and cloned into pGEX-4T (GE Healthcare), leading to an
amino-terminal GST fusion. Correct nucleotide sequences were
verified by DNA sequencing on both strands.
Extract preparation
Whole-cell yeast extracts were produced according to the method
described by Schultz et al. (1991) with modifications. One and a
half liters of yeast culture was grown in YPD to an OD600 of 2.5–5.0
FIGURE 6. In vitro transcription/processing with T3 RNA polymerase. (A) In vitro
transcription/processing reactions with wild-type extracts and templates carrying the CYC1
terminator driven by endogenous RNAP II (lane 1) or with increasing amounts of added T3
RNAP (lanes 2–7). The efficiency of termination/39 end formation in T3 RNAP–dependent
reactions was compared on templates carrying wild-type CYC1 (lane 8), mutant cyc1-512 (lane
9), or no terminator (lane 10). (B) 39 end analysis as outlined in Figure 3D, of time-course of
in vitro transcription/processing reactions dependent on extract endogenous RNAP II and T3
RNAP, as indicated. The upper panel shows nonradioactive PCR reactions that were separated
on 1% agarose gels. The lower panel shows reactions where PCR was performed in the presence
of 59-32P-labelled primer B. Those reaction products were precipitated and resolved on
denaturing 8.3 M urea/6% polyacrylamide gels. The approximate migration of 39 ends carrying
no or 70 adenosine residues, respectively, are indicated. (C) Quantification of results obtained
in A.
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and harvested. The cell pellet was washed twice with ice-cold
ddH2O, resuspended in 10 mL extraction buffer (ET; 200 mM Tris-
HCl at pH 7.5, 0.39 M (NH4)2SO4, 10 mM MgSO4, 10% [v/v]
glycerol, 1 mM EDTA, and 1 mM DTT), and frozen as drops in
liquid nitrogen. Cells were disrupted with three 4-min bursts (to
avoid thawing of the material the chamber was shortly returned to
liquid nitrogen between individual bursts) in a Mixer Mill MM301
using the 50-mL chamber and a single metal ball with 2-cm di-
ameter (Retsch). The obtained cell powder was transferred to a
50-mL Falcon tube and exposed to a stream of cold running water
until the material was thawed (after z30 min). ET (supplemented
with one tablet complete mini protease inhibitors [Roche] and
1 mM PMSF) was added to a final volume of 45 mL, and the lysate
was centrifuged at 10 krpm for 30 min at 4°C in 15-mL Corex
glasses in a Sorvall SS-34 rotor. Following careful removal of the
upper lipid layer, the lysate was further cleared by centrifugation at
32 krpm for 2 h at 4°C in a SW40 rotor. Then 337 mg (NH4)2SO4
was added for each milliliter of the cleared lysate and carefully
stirred in a 50-mL Falcon tube on ice overnight. Precipitated
protein was collected by centrifugation at 15 krpm for 60 min at
4°C in 15-mL Corex glasses in a SS34 rotor; the obtained pellet was
dissolved in 500 mL dialysis buffer (20 mM
HEPES-KOH at pH 7.5, 50 mM KCl, 10 mM
MgSO4, 10 mM EGTA, 20% [v/v] glycerol,
5 mM DTT, 1 mM PMSF) and dialyzed dur-
ing 6 h against three changes of 1.5 L dialysis
buffer. The resulting lysate was collected,
cleared by centrifugation at 14 krpm for 15
min in an Eppendorf 5417R table-top centri-
fuge at 4°C, and stored at 80°C.
Three milliliters of lysate obtained from
ProtA-tagged Pfs2 and ProtA-tagged Rna15
expressing strains was supplemented to reach
final concentrations of 120 mM KCl, 0.01%
(v/v) NP-40, 1 mM PMSF and adsorbed
overnight at 4°C on 300 mL pre-equilibrated
IgG-Sepharose. The beads were then washed
three times for 1 h in dialysis buffer and once
for 15 min in cleavage buffer (10 mM Tris-
HCl at pH 8.0, 150 mM NaCl, 0.1% [v/v]
NP-40, 0.5 mM EDTA, 1 mM DTT). Then
one volume of cleavage buffer was added to
the beads (z300 mL), and elution was started
by addition of 70 U AcTEV protease (Invi-
trogen) following incubation on a rotating
wheel for 3 h at 18°C. The supernatant was
collected and contained partially purified
scCF IA and scCPF, respectively. Protein con-
centrations were estimated to correspond
to 5 ng/mL (scCPF) and 20 ng/mL (scCF IA)
for each band based on intensities following
silver staining.
In vitro transcription/processing
with WCEs
In vitro reactions with WCEs were per-
formed according to the method described
by Rondon et al. (2003), with modifications.
Extract (usually 50–100 mg/mL protein)
containing 200 mg of protein were combined with 100 ng Gal4-
VP16 activator in a 19 mL reaction containing 40 mM HEPES-
KOH (pH 7.8), 10% (v/v) glycerol, 250 mM K-glutamate, and
10 mM K-acetate. Then 19 mL of 23 transcription mix (4% [w/v]
PEG 8000, 80 mM HEPES-KOH at pH 7.5, 10 mM Mg-acetate,
10 mM DTT, 2 mM ATP, 2 mM GTP, 2 mM CTP, 0.2 mM UTP,
80 mM phosphocreatine, 30 mg creatine kinase, 12 U RNase Out)
was added. Following preincubation for 20 min at 25°C, 1 mg
of supercoiled plasmid was added together with 0.25–0.5 mL
a-32P-UTP (3000 Ci/mmol). Unless indicated otherwise, reactions
proceeded for 40 min at 25°C and were terminated with 200 mL
stop buffer (10 mM Tris-HCl at pH 7.5, 0.3 M NaCl, 5 mM
EDTA, 300 U RNase T1). The T1 digest was done for 45 min at
45°C and terminated by addition of 12 mL 10% (v/v) SDS and
20 mg proteinase K, followed by a 30-min incubation at 37°C.
Nucleic acids were extracted with acid phenol/chloroform, pre-
cipitated, washed with 70% EtOH, and dried under vacuum.
RNAs were resolved on 40 cm 6% polyacrylamide/8.3 M urea gels.
Dried gels were exposed to BAS-MS imaging plates (Fujifilm) and
scanned on a FLA 7000 Imaging System (Fujifilm), and quanti-
fication was done with ImageGauge V4.22 software. For numerical
FIGURE 7. In vitro transcription/processing with recombinant CF IA factor (recCF IA. (A)
Increasing amounts of recCF IA reconstituted from Pcf11DN288 (Pcf11 DCID), Clp1, Rna14,
and Rna15 proteins were analyzed by SDS-PAGE and colloidal Coomassie G-250 staining.
Molecular weight standards and their size in kDa are shown on the left. (B) 39 end analysis as
outlined in Figure 3D, of in vitro transcription/processing reactions with ProtA-tagged Rna15
extracts before (lane 1) and after (lanes 2–4) IgG-Sepharose depletion as described in Figure
3A. Reactions were complemented with CF IA factor purified from yeast extract (lane 3) or
with reconstituted CF IA factor (lane 4). (C) In vitro transcription/processing reactions with
constructs carrying the wild-type CYC1 terminator and with extracts before (lanes 1,2) and
after (lanes 3–10) depletion of ProtA-tagged Rna15 protein. Two and four microliters of scCF
IA and recCF IA factor, respectively, was added to depleted extracts as indicated. For control,
reactions were also done with nondepleted extracts on templates carrying the mutant cyc1-512
terminator (lane 2) and in the presence of 4 mM pAp (lanes 4,7,10). (D) Quantification of
results obtained in C.
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analysis, the uridine content (Us) of the individual G-less cassettes
was considered as follows: 84a (18 Us), 84b (24 Us), 100 (29 Us),
120 (36 Us), 131 (40 Us), and 145 (48 Us).
39 end and m7G-cap analysis
A detailed protocol for the ligation-mediated RT-PCR for 39 end
analysis will be described elsewhere (R.A. Alexander, M. Kos, M.C.
Robert, B. Dichtl, J.D. Barrass, T. Obtulowicz, M. Koper, I.
Karkusiewicz, L. Mariconti, D. Tollervey, et al., in prep). To
perform the procedure, in vitro transcription reactions were not
treated with RNase T1, but instead, RNA was immediately extracted
using the Qiagen RNeasy Micro Kit according to manufacturer’s
instructions.
Immunoprecipitation with monoclonal H 20 antibody (Bochnig
et al. 1987) was done essentially as described (Kwan et al. 2000).
Twenty-five microliters protein A–Sepharose CL 4B was prebound
to 10 mL H2O or H 20 antibody, respectively, at 4°C overnight in
a total volume of 200 mL IPP150 (10 mM Tris-HCl at pH 8.0,
150 mM KCl, 0.01% NP-40). RNA isolated from in vitro
transcription reactions was purified with the Qiagen RNeasy
Micro Kit and incubated with the protein A-Sepharose matrix in
the presence of 50 U RNasin for 1 h at 4°C. RNA from unbound
supernatant and pellet fractions was phenol extracted, precipi-
tated, and resolved on 1.2% denaturing formaldehyde gels,
transferred on Hybond N+ membrane, and exposed to a Fujifilm
imaging plate.
Expression and purification of recombinant proteins
His-Clp1, Rna14/His-Rna15, and GST-Pcf11DN288 were overex-
pressed in E. coli strain BL21(DE3)-RIL (Stratagene). Cells
carrying the plasmid for Rna14/His-Rna15 or GST-Pcf11DN288,
respectively, were cultured in 4 L of LB-media, whereas cells
carrying the plasmid for His-Clp1 were cultured in 2 L of LB-
Media at 37°C until they reached an OD600 of 500 and sub-
sequently cooled to 20°C. Protein expression was induced with
0.5 mM isopropyl-b-D-thiogalactopyranoside and continued
overnight with vigorous shaking. Cells were harvested by centri-
fugation (SLC-6000, 20 min, 5500 rpm, 4°C), and the obtained
cell pellets were resuspended in 10 mL per gram of wet cells in the
respective buffer (see below). Cells disruption was done by soni-
cation, and the supernatant was cleared by centrifugation for 1 h
in a SS34 rotor at 13 krpm, 4°C.
His-Clp1 was resuspended in buffer A (50 mM Tris-HCl at pH
8.0, 300 mM KCl, 10 mM b-mercaptoethanol) and purified on
Ni2+-NTA (Qiagen) packed in a column with 1 mL volume. Prior
to protein loading, the column was equili-
brated with buffer A. An high-salt wash with
buffer A and additional 700 mM KCl was
followed by 1 column volume (cv) of buffer
A. His-Clp1 was eluted with buffer A and
250 mM imidazole in a total volume of
6 mL. Rna14/His-Rna15 was resuspended
in buffer B (50 mM Tris-HCl at pH 8.0,
100 mM KCl, 10 mM b-mercaptoethanol).
The subcomplex was loaded on a column
packed with 1 mL Ni2+-NTA equilibrated
with buffer B. After loading, the column was
washed with 1 cv buffer B. Elution was done
in 6 mL of buffer B containing 250 mM imidazole. GST-
Pcf11DN288 was resuspended in buffer C (50 mM Tris-HCl at
pH 7.3, 150 mM KCl, 5 mM dithioerythritol [DTE], 100 mM
ZnCl2). The protein was loaded on a column packed with 8 mL
GSH-Sepharose FF (GE Healthcare). The protein flow was
adjusted such that the load was completed after 2 h. A high-salt
wash with buffer C and 1 M KCl was performed, and afterward,
the column was set back to buffer C in order to perform the
reconstitution of the CF IA. Obtained Rna14/His-Rna15 and His-
Clp1 proteins were diluted in buffer C to a final volume of 40 mL
and loaded for 2 h on the column with immobilized GST-
Pcf11DN288. The column was washed with 1 cv buffer C, and
assembled CF IA was eluted with buffer D (50 mM Tris-HCl at pH
7.3, 200 mM KCl, 5 mM DTE, 100 mM ZnCl2) containing 20 mM
reduced glutathione (Sigma-Aldrich). For removal of the GST-tag
from GST-Pcf11DN288, eluted GSH-Sepharose fractions were
pooled, diluted to 30 mL with buffer D containing 2 mM CaCl2,
and dialyzed in the presence of 160 U thrombin (Sigma-Aldrich)
overnight at 4°C. The assembled CF IA was loaded on a MonoQ
column (cv 8 mL; GE Healthcare) equilibrated with buffer E (50 mM
Tris-HCl at pH 8.0, 5 mM DTE, 100 mM ZnCl2). Elution was
performed in a gradient from buffer E to 60% of buffer F (50 mM
Tris-HCl at pH 8.0, 1 M KCl, 5 mM DTE, 100 mM ZnCl2) over
20 cv. Final purification was performed on a Superose 6 column (cv
23 mL; GE Healthcare) equilibrated with 50 mM HEPES-NaOH
(pH 7.5), 200 mM KCl, and 5 mM DTE. Prior to loading, the
protein sample was concentrated on an Amicon-Ultra device
(Millipore Bioscience; 30-kDa cut-off). The final yield of highly
pure CF IA is 100 mg. All purification steps were monitored by SDS-
PAGE, and protein concentrations were determined spectroscopi-
cally at 280 nm. Correct molecular weight of the single subunits of
CF IA was confirmed by MALDI-TOF mass spectrometry.
Recombinant Gal4-VP16 fusion protein was isolated from
strain XA-90 (kindly provided by J. Jaehning) as described
(Woontner and Jaehning 1990).
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